Allaire, B. T. http://orcid.org/0000-0002-7165-3346
Lu, D.
Johannesdottir, F.
Kopperdahl, D.
Keaveny, T. M.
Jarraya, M.
Guermazi, A.
Bredella, M. A.
Samelson, E. J.
Kiel, D. P.
Anderson, D. E.
Demissie, S.
Bouxsein, M. L.
Funding for this research was provided by:
National Institutes of Health (R01 AR053986, R00 AG042458, R01 AG041658, R01 AR041398)
National Heart, Lung, and Blood Institute (N01-HC-25195)
Article History
Received: 21 December 2017
Accepted: 19 September 2018
First Online: 10 October 2018
Compliance with ethical standards
:
: Brett T. Allaire, Darlene Lu, Fjola Johannesdottir, Mohamed Jarraya, Ali Guermazi, Miriam A. Bredella, Elizabeth J. Samelson, Douglas P. Kiel, Dennis E.Anderson, Serkalem Demissie, and Mary L. Bouxsein declare that they have no conflicts of interest. Dr. Keaveny has been a consultant for Amgen, AgNovos Healthcare, and O.N. Diagnostics and has equity in O.N. Diagnostics. Drs. Keaveny and Kopperdahl have financial interests in O.N. Diagnostics and both they and the company may benefit from the results of this work.